After insurers were mandated to cover at-home Covid-19 tests, more people tested at-home screenings for other conditions, speakers said in a discussion hosted by MedCity INVEST. As preventive tests declined significantly during the pandemic, insurers also turned to creative means to give people access.
Drug analysis company Cellumen has raised about $700,000 this week, bringing their total 2009 fund-raising to $1.3 million.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The company wants to raise the money through debt, a warrant or convertible debt, according to a filing made in February with the Securities and Exchange Commission. It will not offer equity in the company. It raised $8.7 million in July 2007.